48.86USD+3.28%Mkt Cap: 1.47B USDP/E: —Last update: 2026-05-26
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and inf…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap1.47B USD
Enterprise Value1.40B USD
Revenue (TTM)442.68M USD
Gross Profit298.17M USD
Net Income (TTM)-21.02M USD
Revenue/Share15.30 USD
Last Price48.86 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)38.44
PEG—
EV/EBITDA-178.68
EV/Revenue3.17
P/S3.17
P/B4.49
EPS (TTM)-2.66
EPS (Forward)1.23
52W Range
32.2112% of range170.87
52W High170.87 USD
52W Low32.21 USD
Profitability
Gross Margin69.74%
Oper. Margin-25.61%
EBITDA Margin-1.77%
Profit Margin-4.92%
ROE-6.82%
ROA-4.01%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF33.28M USD
CapEx (TTM)19.02M USD
FCF Margin0.82%
FCF Yield0.25%
Net Debt-2.49M USD
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity0.37
Current Ratio3.09
Quick Ratio2.83
Book Value/Sh10.54 USD
Cash/Share5.749 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:33
Split DateMay 4, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)77.00 USD
Target Range50.00 USD – 100.00 USD
# Analysts9
Ownership
Shares Out.29.69M
Float20.00M
Insiders27.00%
Institutions102.07%
Short Interest
Short Ratio6.8d
Short % Float27.36%
Short % Out.14.23%
Shares Short4.22M
Short (prev mo.)3.94M
Technical
SMA 5060.11 (-18.7%)
SMA 200105.73 (-53.8%)
Beta2.07
S&P 52W Chg28.31%
Avg Vol (30d)1.62M
Avg Vol (10d)1.62M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—